Wientjes MHM, Atiqi S, Wolbink GJ, Nurmohamed MT, et al. Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial. Ann Rheum Dis 2025 May 2:S0003-4967(25)00885-4. doi: 10.1016/j.ard.2025.
PMID: 40318979